Search Results - "Fattor, B."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity by Fadini, G P, Zatti, G, Consoli, A, Bonora, E, Sesti, G, Avogaro, A

    “…Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Acipimox-induced facial skin flush : frequency, thermographic evaluation and relationship to plasma acipimox level by PONTIROLI, A. E, FATTOR, B, POZZA, G, PIANEZZOLA, E, STROLIN BENEDETTI, M, MUSATTI, L

    “…Facial skin flush is the most frequent adverse effect induced by acipimox (ACX), a nicotinic acid analogue used in the management of hyperlipidaemia. The aims…”
    Get full text
    Journal Article
  4. 4

    Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine by Pontiroli, A E, Perfetti, M G, Andreotti, A C, Fattor, B, Monti, L D, Pozza, G

    Published in Metabolism, clinical and experimental (01-10-1993)
    “…Insulin inhibits its own release (autofeedback), and growth hormone (GH) inhibits the GH response to a variety of stimuli. The aim of this study was to…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Cross-spectral analysis of cardiovascular variables in supine diabetic patients by Gulli, G, Fattor, Bruno, Marchesi, Mario

    Published in Clinical autonomic research (01-04-2005)
    “…Cardiovascular autonomic neuropathy in diabetes is associated with a high risk of mortality, which makes its early identification clinically important. An easy…”
    Get full text
    Journal Article
  7. 7

    Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study by TOELLER, M, BUYKEN, A, HEITKAMP, G, BRÄMSWIG, S, MANN, J, MILNE, R, GRIES, F. A, KEEN, H

    Published in Diabetologia (01-10-1997)
    “…For people with insulin-dependent diabetes mellitus (IDDM) renal disease represents a life-threatening and costly complication. The EURODIAB IDDM Complications…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study by CHATURVEDI, N, STEPHENSON, J. M, FULLER, J. H

    Published in Diabetes care (01-06-1995)
    “…The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. N Chaturvedi , J M Stephenson and J H Fuller…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study by GREAVES, M, MALIA, R. G, GOODFELLOW, K, MATTOCK, M, STEVENS, L. K, STEPHENSON, J. M, FULLER, J. H

    Published in Diabetologia (01-06-1997)
    “…The interrelationships between fibrinogen, von Willebrand factor, a marker of vascular endothelial cell damage, and serum lipids were explored in…”
    Get full text
    Journal Article
  11. 11

    Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus by Buyken, A. E., Toeller, M., Heitkamp, G., Irsigler, K., Holler, C., Santeusanio, F., Stehle, P., Fuller, J. H., Group, The Eurodiab Iddm Complications Study

    Published in Diabetic medicine (01-05-2000)
    “…Summary Aims Little information is available on the relationship betweeen glycated haemoglobin levels and the source or amount of dietary carbohydrate. The…”
    Get full text
    Journal Article
  12. 12

    Blood pressure, retinopathy and urinary albumin excretion in IDDM : the EURODIAB IDDM complications study by STEPHENSON, J. M, FULLER, J. H, VIBERTI, G.-C, SJOLIE, A.-K, NAVALESI, R

    Published in Diabetologia (01-05-1995)
    “…Several studies have shown an association between blood pressure and nephropathy, but few have been large enough to examine whether, or how, this relation is…”
    Get full text
    Journal Article
  13. 13

    Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium by Davalli, A M, Ricordi, C, Socci, C, Braghi, S, Bertuzzi, F, Fattor, B, Di Carlo, V, Pontiroli, A E, Pozza, G

    “…In the experimental animal chronic hyperglycemia alters the islet's sensitivity to glucose. In the present study the glucose sensitivity of human pancreatic…”
    Get more information
    Journal Article
  14. 14

    Repeatability of three-day dietary records in the EURODIAB IDDM complications study by TOELLER, M, BUYKEN, A, HEITKAMP, G, MILME, R, KLISCHAN, A, GRIES, F. A

    Published in European journal of clinical nutrition (01-02-1997)
    “…Repeatability of a dietary method is important in determining the quality of nutritional data. It should be assessed in the population of interest. This study…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The relationship between pregnancy and long-term maternal complications in the EURODIAB IDDM Complications Study by Chaturvedi, N, Stephenson, J M, Fuller, J H

    Published in Diabetic medicine (01-06-1995)
    “…Pregnancy is believed to exacerbate diabetes complications, although the degree to which this occurs, and the advice that should be given to women…”
    Get more information
    Journal Article
  17. 17

    Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate by Pontiroli, A E, Perfetti, M G, Fattor, B, Pozza, G

    “…Several peptide hormones are effective when administered intranasally (in); these include oxytocin, vasopressin, insulin, glucagon, and calcitonin. With regard…”
    Get more information
    Journal Article